London Stock Exchange | GenomeWeb

London Stock Exchange

Osmetech is betting the five-year deal will expand its sales and marketing efforts in the US and allow it to allocate more resources towards bringing its pipeline of tests to market.

Life Technologies announced today that it has been named to the FTSE4 Good Index Series, which includes companies that reach rigorous social, ethical, and environmental criteria.

Industry Briefs

Premium

Bruker, NextGen, Sigma-Aldrich, Bio-Rad, Waters, Pressure BioSciences, PSI, Xencor, Pfizer

The $3 million Stem Cell Commercialization Facility will open in June within 2,508 square feet of TechOne, the 100,000-square-foot first building of up to three that are planned to comprise the tech park, called TechTown.

Tepnel's shareholders will vote on the deal next month, with the $132.1 million offer expected to take effect in April.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.